Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 2Dermatologic 2

Conditions

Keratosis, Actinic 16Glioblastoma 4Brain Neoplasms 3Skin Diseases 2Precancerous Conditions 2Glioma 2Skin Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Meningioma 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

binimetinib 2Watchful Waiting 2Aminolevulinic Acid 2palbociclib 1ipatasertib 1exemestane 1encorafenib 1baricitinib 1atezolizumab 1Vemurafenib 1VP-102 1Trabectedin 1Paclitaxel 1Injections, Intradermal 1Gonadotropin-Releasing Hormone 1Everolimus 1Dacarbazine 1Cantharidin 1BF-200 ALA 1Anastrozole 1AZD9833 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Skin Diseases × Aminolevulinic Acid × Clear all
NCT07144345 2026-04-22

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

Sun Pharmaceutical Industries Limited

Phase 3 Recruiting
160 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT07144852 2026-04-22

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

Sun Pharmaceutical Industries Limited

Phase 3 Recruiting
260 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡